GD2-CAR-NK in combination with Smac Mimetics: A Novel Therapeutic Strategy Against High-Risk Neuroblastoma
GD2-CAR-NK in combination with Smac Mimetics: A Novel Therapeutic Strategy Against High-Risk Neuroblastoma
GD2-CAR-NK 与 Smac Mimetics 联合：针对高风险神经母细胞瘤的新型治疗策略
批准号：
467077
负责人：
Hakoum Mariam
金额：
$1.27万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-12-01 至 2022-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neuroblastoma (NB) is the second most common pediatric solid tumor cancer of immature nerve cells. NB tumors have a diverse range of clinical behaviors, from spontaneous regression in infants under 24 months to a highly recurrent and aggressive malignancy
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
